Compare AVTR & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVTR | PTGX |
|---|---|---|
| Founded | 1904 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 9.3B |
| IPO Year | 2019 | 2016 |
| Metric | AVTR | PTGX |
|---|---|---|
| Price | $17.19 | $139.17 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 16 | 14 |
| Target Price | $15.46 | ★ $178.21 |
| AVG Volume (30 Days) | ★ 8.0M | 722.9K |
| Earning Date | 10-28-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.06 | ★ 2.35 |
| Revenue | ★ $6,552,200,000.00 | N/A |
| Revenue This Year | $0.64 | $1,077.07 |
| Revenue Next Year | $2.27 | N/A |
| P/E Ratio | $284.58 | ★ $59.42 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.27 | $74.03 |
| 52 Week High | $17.45 | $160.81 |
| Indicator | AVTR | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 73.74 | 48.84 |
| Support Level | $13.20 | $135.10 |
| Resistance Level | N/A | $142.20 |
| Average True Range (ATR) | 0.48 | 6.12 |
| MACD | 0.14 | 0.22 |
| Stochastic Oscillator | 89.36 | 49.12 |
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.